FILTER

FILTERED INTERVIEW RESULTS

Mining
DRC
MACIG

Louis Watum

PRESIDENT, CHAMBER OF MINES DRC
"I am concerned that the DRC is not fully capturing the opportunities of the commodity boom."
Mining
DRC
MACIG

Hadley Natus

CHAIRMAN, TANTALEX LITHIUM RESOURCES
"I think Manono, for lithium, could become what Katanga has become for copper, and much more."
Mining
Ghana
MACIG

Eric Waldner

CEO, NEXANS KABELMETAL GHANA
"Ghana set an ambitious goal to be 100% electrified by 2024, which will be massively pushing our growth forward."
Mining
Ghana
MACIG

George Arhin

PARTNER AND PWC WEST AFRICA MINING LEADER
"This is the best time for mining companies to invest in cost optimization solutions to sustain their business when the gold prices dip."
Mining
Canada

Alex Christopher

38TH PRESIDENT, PROSPECTORS & DEVELOPERS ASSOCIATION OF CANADA (PDAC)
"PDAC’s focus is to ensure that the mineral sector remains viable through the pandemic."
Mining
Canada

John McCluskey

PRESIDENT & CEO, ALAMOS GOLD
"Since 2015, Alamos has spent close to C$2 billion on acquisitions in Canada, while creating thousands of jobs."
Mining
United States

Robert Archer

PRESIDENT & CEO, NEWRANGE GOLD CORP.
"In 2022, the company will initially focus on its gold projects in Canada while grooming the Pamlico project in Nevada for additional drilling."
Mining
Peru

Patrick Elliott

PRESIDENT & CEO, FORTE MINERALS CORP.
Patrick Elliott introduces Forte Minerals Corp, Peru’s newest listed junior.
Mining
Canada

Paul Healy

PRESIDENT AMERICAS, REDPATH MINING
"Canada remains our base especially for the technical aspect of our operations for which we rely on local Canadian skills."
Mining
Canada

Tom Larsen & Bill Pearson

CEO & EXECUTIVE VICE PRESIDENT OF EXPLORATION, ELORO RESOURCES
"The Bolivian mining industry is still in a place where they need outside expertise and that is where we are fortunate to be accepted in the country."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL